Biogen
About Biogen
Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Biogen is advancing a pipeline of potential novel therapies across neurology, neuropsychiatry, specialized immunology and rare diseases and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.
Company Ownership: Public
Stock Symbol: BIIB
Stock Exchange: NASDAQ
At Biogen we are connected by a greater purpose to help improve the lives of patients, work fearlessly, and grow together. Hear from the best and brightest at Biogen on what inspires them every day and why you should join our team.
1891 articles about Biogen
-
The Day In Review: Biotech Tacks On More Gains
8/3/2005
-
Biogen Idec, Inc. (Massachusetts) Reports Second Quarter 2005 Results
7/27/2005
-
Day In Review: Fed Move Sends Biotech Lower
6/30/2005
-
Biogen Idec, Inc. Release: The World's Largest Observational Study Of Interferon-Beta Products For Relapsing Multiple Sclerosis Advances Understanding Of Long-Term MS Management
6/28/2005
-
Novartis AG Is Seeking To Beat Serono International S.A. To First Multiple Sclerosis Pill
6/20/2005
-
Will A Blood Test Allow Tysabri To Return To Market?
6/9/2005
-
Biologics Warfare
5/5/2005
-
The Day In Review: Oil Slide Sends Biotech Higher
4/29/2005
-
Tysabri 2-Year MS Study: The Battle Is Joined
4/13/2005
-
Biogen Idec, Inc. (BIIB) Release: BG-12 Psoriasis Study Meets Primary Endpoint; Oral Compound Also Being Studied For MS In Phase II Trial
4/7/2005
-
BG-12 From Biogen Idec Effective Against Psoriasis
4/7/2005
-
The Day In Review: Biotech Gains A Substantial 1+%; A Wealth of Positive News Helps Sector Move Higher
4/6/2005
-
Tysabri Dominates Biotech News Again
3/31/2005
-
Biogen Idec, Inc. (BIIB) Withdraws 2005 Fnancial Guidance
3/31/2005
-
Is Tysabri Finished? Another Death Found...
3/30/2005
-
Biogen Idec, Inc. (Massachusetts) To Present At Eighth Annual Lehman Brothers' Global Healthcare Conference
3/30/2005
-
Eli Lilly Turns To Japan
3/25/2005
-
The Day In Review: Biogen Idec Warning Sends Biotech Lower
3/16/2005
-
Biotech Bargain Hunting
3/14/2005
-
The Day In Review: Biotech Sinks, Broad Market Swims
3/4/2005